Nouveau Life Pharmaceuticals (NOUV) Releases Glucosamine Supplement to Support Healthy Joints
FORT LAUDERDALE, Fla., July 17, 2012 /PRNewswire/ — Nouveau Life Pharmaceuticals, Inc. (OTC Pink: NOUV), a provider of quality all-natural dietary supplements, announced today the release of its newest supplement product: New Life Naturals: For Your Joint Health(TM).
For Your Joint Health(TM) is a Glucosamine Sulfate supplement that was developed by Nouveau Life as part of the Company’s focus on health concerns for Baby Boomers and aging adults. Glucosamine Sulfate is a naturally occurring chemical found in the body in the fluid that is around joints. Glucosamine Sulfate is commonly used to support joint health in people suffering from arthritis, most often osteoarthritis. Osteoarthritis is the most common type of arthritis. It is estimated that roughly 12 percent of the U.S. population age 25 and older (nearly 21 million Americans) and 15% of the global population (approximately 630 million people worldwide) have osteoarthritis.
New Life Naturals: For Your Joint Health(TM) is available for purchase at the Nouveau Life online store: www.nlpnaturals.com. The recommended dose is one to three tablets daily. Each bottle contains 120 tablets and retails for $12.99.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements – This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.
Nouveau Life Pharmaceuticals, Inc. – 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.